Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley K Uppal

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Dermatologic Therapy|January 9, 2021
The clinical utility of teledermoscopy in the era of telemedicineShelley K Uppal, Jacob Beer, Edward Hadeler, et al.
Lancet (London, England)|January 17, 2021
Abrocitinib for atopic dermatitisShelley K Uppal, Vipawee S Chat, Donovan G Kearns, et al.
Cutis|January 19, 2021
Dermatologists as social media contributors during the COVID-19 pandemicShelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Dermatologic Therapy|May 15, 2021
Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive reviewVipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Topical Agents Currently in Phase II or Phase III Trials for Atopic DermatitisShelley K Uppal, Vipawee S Chat, Donovan G Kearns, et al.
Lancet (London, England)|November 29, 2020
Ruxolitinib cream for the treatment of vitiligoShelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
The Journal of Dermatological Treatment|November 6, 2019
Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapyVipawee S Chat, Donovan G Kearns, Shelley K Uppal, et al.
The Journal of Dermatological Treatment|June 23, 2020
Clinical management of psoriasis patients during the COVID-19 pandemicVipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Journal of Drugs in Dermatology : JDD|July 7, 2021
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
The Journal of Dermatological Treatment|June 9, 2020
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitisShelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Dermatologic Therapy|January 9, 2021
The clinical utility of teledermoscopy in the era of telemedicineShelley K Uppal, Jacob Beer, Edward Hadeler, et al.
Lancet (London, England)|January 17, 2021
Abrocitinib for atopic dermatitisShelley K Uppal, Vipawee S Chat, Donovan G Kearns, et al.
Cutis|January 19, 2021
Dermatologists as social media contributors during the COVID-19 pandemicShelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Dermatologic Therapy|May 15, 2021
Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive reviewVipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Topical Agents Currently in Phase II or Phase III Trials for Atopic DermatitisShelley K Uppal, Vipawee S Chat, Donovan G Kearns, et al.
Lancet (London, England)|November 29, 2020
Ruxolitinib cream for the treatment of vitiligoShelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
The Journal of Dermatological Treatment|November 6, 2019
Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapyVipawee S Chat, Donovan G Kearns, Shelley K Uppal, et al.
The Journal of Dermatological Treatment|June 23, 2020
Clinical management of psoriasis patients during the COVID-19 pandemicVipawee S Chat, Shelley K Uppal, Donovan G Kearns, et al.
Journal of Drugs in Dermatology : JDD|July 7, 2021
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
The Journal of Dermatological Treatment|June 9, 2020
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitisShelley K Uppal, Donovan G Kearns, Vipawee S Chat, et al.
Pageof 2